Last reviewed · How we verify
NCT02912299: InCa
Investigation on Differences in Skin Sodium Content Between Normal Subjects and ICU-patients
trial testing Skin biopsies in Hypernatremia in 45 participants. Completed in 5 September 2017.
5 September 2017
Quick facts
| Lead sponsor | Frisius Medisch Centrum |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 45 |
| Start date | 3 November 2016 |
| Primary completion | 5 September 2017 |
| Estimated completion | 5 September 2017 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Skin biopsies — full drug profile →
- Blood and urine analysis
- Blood collection for RNA-investigation
Conditions studied
- Hypernatremia — all drugs for Hypernatremia →
Sponsor
Frisius Medisch Centrum — full company profile →
Who can join
Adults 45 to 85, any sex, with Hypernatremia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the differens in sodium storage in skin between normal subjects, patients after cardiac surgery and septic patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An observational study on intracutaneous sodium storage in intensive care patients and controls.
van IJzendoorn M, van den Born J, Hijmans R, Bodde R, et al · · 2019 · cited 1× · PMID 31581250 · DOI 10.1371/journal.pone.0223100
Verify or expand the search:
- PubMed search for NCT02912299
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Skin biopsies
Trials testing the same drug.
- NCT06111950 — Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes · NA · recruiting
- NCT06124781 — Molecular Diagnosis of Allergic Contact Dermatitis (SMECA). · NA · unknown
- NCT05532865 — Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking · recruiting
- NCT03976622 — Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia · unknown
- NCT03553823 — Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab · Phase 2 · completed
Other Frisius Medisch Centrum trials
Trials by the same sponsor.
- NCT06249035 — Feasibility of TEE During Cardiac Arrest in Dutch Emergency Departments · NA · recruiting
- NCT06558630 — ED Airway Management in the Netherlands. · recruiting
- NCT06202729 — Focus on Experienced Anxiety Related to an Emergency Department Visit · completed
- NCT05732363 — Evaluation of Different Methods to Measure Muscle Mass and Strength in a Population With Class II/III Obesity · completed
- NCT06119711 — Micronutrient Levels and Nutritional Status in Critical Illness · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02912299 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Frisius Medisch Centrum
- Last refreshed: 8 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02912299.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing